TY - JOUR
T1 - Insights into ancestral diversity in Parkinson’s disease risk
T2 - a comparative assessment of polygenic risk scores
AU - Saffie-Awad, Paula
AU - Grant, Spencer M.
AU - Makarious, Mary B.
AU - Elsayed, Inas
AU - Sanyaolu, Arinola O.
AU - Crea, Peter Wild
AU - Schumacher Schuh, Artur F.
AU - Levine, Kristin S.
AU - Vitale, Dan
AU - Koretsky, Mathew J.
AU - Kim, Jeffrey
AU - Peixoto Leal, Thiago
AU - Periñán, María Teresa
AU - Dey, Sumit
AU - Noyce, Alastair J.
AU - Reyes-Palomares, Armando
AU - Rodriguez-Losada, Noela
AU - Foo, Jia Nee
AU - Mohamed, Wael
AU - Heilbron, Karl
AU - Norcliffe-Kaufmann, Lucy
AU - Wong, Corinna D.
AU - Wilton, Peter
AU - Weldon, Catherine H.
AU - Wang, Wei
AU - Wang, Xin
AU - Tung, Joyce Y.
AU - Tran, Vinh
AU - Tchakouté, Christophe Toukam
AU - Tat, Susana A.
AU - Su, Qiaojuan Jane
AU - Shringarpure, Suyash
AU - Shi, Jingchunzi
AU - Shelton, Janie F.
AU - Shastri, Anjali J.
AU - Schumacher, Morgan
AU - Schloetter, Madeleine
AU - Reynoso, Alexandra
AU - Poznik, G. David
AU - Petrakovitz, Aaron A.
AU - O’Connell, Jared
AU - Noblin, Elizabeth S.
AU - Nguyen, Dominique T.
AU - Nandakumar, Priyanka
AU - Moreno, Meghan E.
AU - Micheletti, Steven J.
AU - McIntyre, Matthew H.
AU - McCreight, Jey C.
AU - Lowe, Maya
AU - Krüger, Rejko
AU - The 23andMe Research Team
AU - Global Parkinson’s Genetics Program (GP2)
N1 - Publisher Copyright:
© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025.
PY - 2025/7/3
Y1 - 2025/7/3
N2 - Risk prediction models play a crucial role in advancing healthcare by enabling early detection and supporting personalized medicine. Nonetheless, polygenic risk scores (PRS) for Parkinson’s disease (PD) have not been extensively studied across diverse populations, contributing to health disparities. In this study, we constructed 105 PRS using individual-level data from seven ancestries and compared two different models. Model 1 was based on the cumulative effect of 90 known European PD risk variants, weighted by summary statistics from four independent ancestries (European, East Asian, Latino/Admixed American, and African/Admixed). Model 2 leveraged multi-ancestry summary statistics using a p-value thresholding approach to improve prediction across diverse populations. Our findings provide a comprehensive assessment of PRS performance across ancestries and highlight the limitations of a “one-size-fits-all” approach to genetic risk prediction. We observed variability in predictive performance between models, underscoring the need for larger sample sizes and ancestry-specific approaches to enhance accuracy. These results establish a foundation for future research aimed at improving generalizability in genetic risk prediction for PD.
AB - Risk prediction models play a crucial role in advancing healthcare by enabling early detection and supporting personalized medicine. Nonetheless, polygenic risk scores (PRS) for Parkinson’s disease (PD) have not been extensively studied across diverse populations, contributing to health disparities. In this study, we constructed 105 PRS using individual-level data from seven ancestries and compared two different models. Model 1 was based on the cumulative effect of 90 known European PD risk variants, weighted by summary statistics from four independent ancestries (European, East Asian, Latino/Admixed American, and African/Admixed). Model 2 leveraged multi-ancestry summary statistics using a p-value thresholding approach to improve prediction across diverse populations. Our findings provide a comprehensive assessment of PRS performance across ancestries and highlight the limitations of a “one-size-fits-all” approach to genetic risk prediction. We observed variability in predictive performance between models, underscoring the need for larger sample sizes and ancestry-specific approaches to enhance accuracy. These results establish a foundation for future research aimed at improving generalizability in genetic risk prediction for PD.
UR - https://www.scopus.com/pages/publications/105012492428
U2 - 10.1038/s41531-025-00967-4
DO - 10.1038/s41531-025-00967-4
M3 - Article
C2 - 40610451
AN - SCOPUS:105012492428
SN - 2373-8057
VL - 11
JO - npj Parkinson's Disease
JF - npj Parkinson's Disease
IS - 1
M1 - 201
ER -